| scholarly article | Q13442814 |
| P50 | author | Fritz Diekmann | Q43278879 |
| Maria Meneghini | Q87020151 | ||
| P2093 | author name string | Ignacio Revuelta | |
| David Cucchiari | |||
| Edoardo Melilli | |||
| Josep M Cruzado | |||
| Josep M Grinyó | |||
| Oriol Bestard | |||
| Jaume Martorell | |||
| Anna Manonelles | |||
| Nuria Montero | |||
| Salvador Gil-Vernet | |||
| Elisabet Rigol-Monzó | |||
| P2860 | cites work | Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial | Q34373536 |
| Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. | Q35027253 | ||
| Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians | Q36007256 | ||
| OPTN/SRTR 2015 Annual Data Report: Kidney | Q36239725 | ||
| Donor-specific antibodies adversely affect kidney allograft outcomes. | Q36426146 | ||
| Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients | Q36772957 | ||
| Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation. | Q38726059 | ||
| Relationship between Mean Fluorescence Intensity and C1q/C3d-fixing capacities of anti-HLA antibodies | Q38965721 | ||
| The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors | Q39979362 | ||
| Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss | Q40634986 | ||
| Assessing Antibody Strength: Comparison of MFI, C1q, and Titer Information. | Q40990548 | ||
| Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients | Q43829155 | ||
| Quantifying the risk of incompatible kidney transplantation: a multicenter study. | Q44753304 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment | Q46970385 | ||
| Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients | Q47313617 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation | Q48255248 | ||
| Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. | Q50654391 | ||
| Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. | Q50879242 | ||
| Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates. | Q50993047 | ||
| Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. | Q51775005 | ||
| UK Renal Registry 16th Annual Report: Chapter 4 Demography of Patients Waitlisted for Renal Transplantation in the UK: National and Centre-specific Analyses | Q56974238 | ||
| The flow cytometric crossmatch and early renal transplant loss | Q68412861 | ||
| Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch | Q77309279 | ||
| Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss | Q81947599 | ||
| Interpretation of positive flow cytometric crossmatch in the era of the single-antigen bead assay | Q83063969 | ||
| Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow… | Q87069020 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 926-938 | |
| P577 | publication date | 2018-03-30 | |
| P1433 | published in | KI reports | Q27727507 |
| P1476 | title | Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome | |
| P478 | volume | 3 |
Search more.